Viral and host genetic factors regulating HIV/CNS disease

References

• Barber SA, Herbst DS, Bullock BT, Gama L, Clements JE (2004). Innate immune responses and control of acute SIV replication in the CNS. J Neurovirol 10(Suppl 1): S15–S20.
   Google Scholar
• Bestetti A, Presi S, Pierotti C, Bossolasco S, Sala S, Racca S, Carrera P, Lazzarin A, Cinque P (2004). Long-term virological effect of HAART in cerebrospinal fluid and relationship with genotypic resistance. J Neurovirol 10(Suppl 1): S52–S57.
   Google Scholar
• Brandimarti B, Khan MZ, Fatatis A, Meucci O (2004). Regulation of cell cycle proteins by chemokine receptors: a novel pathway in HIV neuropathogenesis. J Neurovirol 10(Suppl 1): S108–S112.
   Google Scholar
• Buch S, Sui Y, Potula R, Pinson D, Adany I, Li Z, Huang M, Li S, Dhillon N, Major E, Narayan O (2004). Role of interleukin-4 and monocyte chemoattractant protein-1 in the neuropathogenesis of X4-SHIV infection in macaques. J Neurovirol 10(Suppl 1): S118–S124.
   Google Scholar
• Burdo TH, Gartner S, Mauger D, McArthur J, Wigdahl B (2004). Region-specific distribution of HIV-1 LTRs containing specific configurations of C/EBP site II in brains derived from demented and non-demented patients. J Neurovirol 10(Suppl 1): S7–S14.
   Google Scholar
• Diaz-Arrastia R, Gong Y, Kelly CJ, Gelman BB (2004). Host genetic polymorphisms in HIV related neurologic disease. J Neurovirol 10(Suppl 1): S67–S73.
   Google Scholar
• Ellis RJ, Gamst AC, Capparelli E, Spector SA, Hsia K, Wolfson T, Abramson I, Grant I, McCutchan JA (2000). Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources. Neurology 54: 927–936.
   PubMed Web of Science ®Google Scholar
• Gonzalez E, Rovin BH, Sen L, Cooke G, Dhanda R, Mummidi S, Kulkarni H, Bamshad MJ, Telles V, Anderson SA, Walter EA, Stephan KT, Deucher D, Mangano A, Bologna R, Ahuja SS, Dolan MJ, Ahuja SK (2002). HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Proc Natl Acad Sci USA 99: 13795–13800.
   PubMed Web of Science ®Google Scholar
• Haas DW (2004). Sequence heterogeneity and viral dynamics in cerebrospinal fluid and plasma during antiretroviral therapy. J Neurovirol 10(Suppl 1): S33–S37.
   Google Scholar
• Keppler OT, Welte FJ, Ngo TA, Chin PS, Patton KS, Tsou CL, Abbey NW, Sharkey ME, Grant RM, You Y, Scarborough JD, Ellmeier W, Littman DR, Stevenson M, Charo IF, Herndier BG, Speck RF, Goldsmith MA (2002). Progress toward a human CD4/CCR5 transgenic rat model for de novo infection by human immunodeficiency virus type 1. J Exp Med 195: 719–736.
   PubMed Web of Science ®Google Scholar
• Lawrence DM and Major EO (2002). HIV-1 and the brain: connections between HIV-1-associated dementia, neuropathology and neuroimmunology. Microb Infect 4: 301–308.
   PubMed Web of Science ®Google Scholar
• Liu Y, Tang XP, McArthur JC, Scott J, Gartner S (2000). Analysis of human immunodeficiency virus type 1 gp160 sequences from a patient with HIV dementia: evidence for monocyte trafficking into brain. J Neurovirol 6(Suppl 1): S70–S81.
   PubMed Web of Science ®Google Scholar
• Nukuna A, Gendelman HE, Limoges J, Rasmussen J, Poluektova L, Ghorpade A, Persidsky Y (2004). Level of HIV-1 infection in macrophages determines the severity of HIV-1 encephalitis in SCID mice. J Neurovirol 10(Suppl 1): S82–S90.
   Google Scholar
• Petito CK (2004). HIV-1 compartmentalization in the central nervous system. J Neurovirol 10(Suppl 1): S21–S24.
   PubMedGoogle Scholar
• Power C, Zhang K, van Marle G (2004). Comparative neurovirulence in lentiviral infections: the roles of viral molecular diversity and select proteases. J Neurovirol 10(Suppl 1): S113–S117.
   Google Scholar
• Price RW, Deeks SJ (2004). Antiretroviral drug treatment interruption in HIV infected adults: clinical and pathogenic implications for the central nervous system. J Neurovirol 10(Suppl 1): S44–S51.
   Google Scholar
• Ryzhova EV, Crino P, Shawver L, Westmoreland SV, Lackner AA, Gonzalez-Scarano F (2002). Simian immunodeficiency virus encephalitis: analysis of envelope sequences from individual brain multinucleate giant cells and tissue samples. Virol 297: 57–67.
   PubMed Web of Science ®Google Scholar
• Wang TH, Donaldson YK, Brettle RP, Bell JE, Simmonds P (2001). Identification of shared populations of human immunodeficiency virus type 1 infecting microglia and tissue macrophages outside the central nervous system. J Virol 75: 11686–11699.
   PubMed Web of Science ®Google Scholar
• Wang Z, Trillo-Pazos G, Kim SY, Canki M, Morgello S, Sharer LR, Gelbard HA, Su ZZ, Kang DC, Brooks AI, Fisher PB, Volsky DJ (2004). Effect of HIV-1 on astrocyte gene expression and function: potential role in neuropathogenesis. J Neurovirol 10(Suppl 1): S25–S32.
   PubMedGoogle Scholar
• Williams K, Schwartz, Corey S, Orandle M, Kennedy W. Thompson I, Alvarez X, Brown C, Gartner S, Lackner A (2002). Proliferating cellular nuclear antigen expression as a marker of perivascular macrophages in simian immunodeficiency virus encephalitis. Am J Pathol 161: 575–585.
   Google Scholar
• Wojna V, Carlson KA, Luo X, Mayo R, Melendez LM, Kraiselburd E, Gendelman HE (2004). Proteomic fingerprinting of HIV-1 associated dementia from patient monocyte-derived macrophages: A case study. J Neurovirol 10(Suppl 1): S74–S81.
   PubMedGoogle Scholar
• Yi Y, Lee C, Liu QH, Freedman BD, Collman RG (2004). Chemokine receptor utilization and macrophage signaling by HIV-1 gp120: Implications for neuropathogenesis. J Neurovirol 10(Suppl 1): S91–S96.
   Google Scholar